Use of self-controlled designs in pharmacoepidemiology

Journal of Internal Medicine

Volumn 275, Issue 6, 2014, Pages 581-589

  Hallas, J ^a   Pottegard A ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adverse drug effects; Design; Epidemiology; Methods

Indexed keywords

ADVERSE DRUG REACTION; ANGER; CASE STUDY; CLINICAL RESEARCH; CROSSOVER PROCEDURE; DEPRESSION; DRUG EXPOSURE; EXERCISE; FOLLOW UP; HUMAN; LONG TERM EXPOSURE; OBSERVATIONAL STUDY; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SECONDARY HEALTH CARE; SEXUAL BEHAVIOR; STRENGTH; TIME;

ADVERSE DRUG EFFECTS; DESIGN; EPIDEMIOLOGY; METHODS;

BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; CAUSALITY; CONFOUNDING FACTORS (EPIDEMIOLOGY); EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; OBSERVATIONAL STUDY AS TOPIC; PHARMACOEPIDEMIOLOGY; STATISTICS AS TOPIC;

EID: 84902006344     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12186     Document Type: Review

References (24)

1. Miettinen OS. The need for randomization in the study of intended effects. Stat Med 1983; 2: 267-71.
2. Maclure M. 'Why me?' versus 'why now?'-differences between operational hypotheses in case-control versus case-crossover studies. Pharmacoepidemiol Drug Saf 2007; 16: 850-3.
3. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991; 133: 144-53.
4. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N Engl J Med 1993; 329: 1677-83.
5. Mittleman MA, Maclure M, Sherwood JB et al. Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation 1995; 92: 1720-5.
6. Muller JE, Mittleman MA, Maclure M, Sherwood JB, Tofler GH. Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. Determinants of Myocardial Infarction Onset Study Investigators. JAMA 1996; 275: 1405-9.
7. Suissa S. The case-time-control design. Epidemiology 1995; 6: 248-53.
8. Hallas J, Bjerrum L, Stovring H, Andersen M. Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study. Am J Epidemiol 2008; 168: 966-73.
9. Greenland S. Confounding and exposure trends in case-crossover and case-time-control designs. Epidemiology 1996; 7: 231-9.
10. Wang S, Linkletter C, Maclure M et al. Future cases as present controls to adjust for exposure trend bias in case-only studies. Epidemiology 2011; 22: 568-74.
11. Farrington P, Pugh S, Colville A et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 1995; 345: 567-9.
12. Maclure M, Fireman B, Nelson JC et al. When should case-only designs be used for safety monitoring of medical products? Pharmacoepidemiol Drug Saf 2012; 21(Suppl 1): 50-61.
13. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006; 25: 1768-97.
14. Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology 1996; 7: 478-84.
15. Cher DJ. Myocardial infarction and acute cholecystitis: an application of sequence symmetry analysis. Epidemiology 2000; 11: 446-9.
16. Garrison SR, Dormuth CR, Morrow RL, Carney GA, Khan KM. Nocturnal leg cramps and prescription use that precedes them: a sequence symmetry analysis. Arch Intern Med 2012; 172: 120-6.
17. Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf 2009; 18: 483-91.
18. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000; 55: 987-99.
19. Crawford D, Jeffery RW, French SA. Can anyone successfully control their weight? Findings of a three year community-based study of men and women. Int J Obes Relat Metab Disord 2000; 24: 1107-10.
20. Hallas J, Bytzer P. Screening for drug related dyspepsia: an analysis of prescription symmetry. Eur J Gastroenterol Hepatol 1998; 10: 27-32.
21. Bytzer P, Hallas J. Drug-induced symptoms of functional dyspepsia and nausea. A symmetry analysis of one million prescriptions. Aliment Pharmacol Ther 2000; 14: 1479-84.
22. Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012; 19: 54-60.
23. Robb MA, Racoosin JA, Worrall C, Chapman S, Coster T, Cunningham FE. Active surveillance of postmarket medical product safety in the federal partners' collaboration. Med Care 2012; 50: 948-53.
24. Power G, Painter J. Performance of observational screening by system organ class. Pharmacoepidemiol Drug Saf 2012; 21(suppl 3): 231.